Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from Vera Bradley's 2026 Annual Meeting of Shareholders held on June 4, 2026, covering four matters: election of six directors, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2020 Equity and Incentive Plan. The filing presents detailed vote tallies (for, against, abstentions, and broker non-votes) for each matter, which is the hallmark of Item 5.07 disclosure and constitutes material information for investors regarding corporate governance and shareholder decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Titan Machinery's Annual Meeting held on June 8, 2026. The filing presents voting tallies for three proposals: election of Class I directors (Christianson, Hamilton, Knutson), approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder confidence in management and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Arcutis held its Annual Meeting of Stockholders on June 5, 2026, with shareholders voting on three proposals: election of three Class III directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals were approved.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from Traeger's June 9, 2026 annual meeting of stockholders under Item 5.07. The filing reports voting outcomes for two proposals: (1) election of Class II directors (Martin Eltrich and Steven Richman) with vote tallies, and (2) ratification of Ernst & Young LLP as independent auditor. Both proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Alignment Healthcare's annual stockholder meeting held June 4, 2026. The filing presents voting outcomes for three proposals: election of three Class II directors (Jody Bilney, David Hodgson, and Jacqueline Kosecoff), ratification of Deloitte & Touche LLP as independent auditor, and an advisory say-on-pay vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm governance and audit oversight decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on June 9, 2026, covering three proposals: election of eight directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing explicitly states the vote tallies and outcomes for each proposal, which is the core content of Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder voting results from the June 9, 2026 Annual Meeting of Stockholders. The filing presents detailed vote tallies for four proposals: election of three Class II directors (Amir Bacchus, Mark Thierer, and Lawrence B. Leisure), ratification of BDO USA as independent auditor, advisory approval of named executive officer compensation, and approval of warrant issuance. All proposals passed. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and key corporate governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from Klaviyo's 2026 annual meeting held on June 9, 2026, covering three proposals: election of three Class III directors (Jennifer Ceran, Chano Fernández, and Susan St. Ledger), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of Stockholders. The filing presents voting tallies for two proposals: (1) election of eight directors to the Board, with individual vote counts for each nominee (votes for, against, abstained, and broker non-votes), and (2) ratification of Deloitte & Touche LLP as independent auditor. All directors were elected and the auditor was ratified. This is a material disclosure as shareholder voting outcomes affect governance and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
NCR Voyix held its Annual Meeting of Stockholders on June 3, 2026, with shareholders voting on four proposals: election of eight directors, a say-on-pay advisory vote, ratification of PricewaterhouseCoopers LLP as auditor, and approval of the 2026 Stock Incentive Plan. All four proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Semtech held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on four proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the Amended and Restated 2017 Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Hawthorn Bancshares held its 2026 Annual Meeting of Shareholders on June 2, 2026, with voting results on four proposals: election of four Class I directors, ratification of Forvis Mazars as independent auditor, advisory approval of executive compensation, and frequency of compensation votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing presents detailed voting tallies for three proposals: election of four Class II directors (Proposal 1), advisory say-on-pay vote on named executive officer compensation (Proposal 2), and ratification of RSM US LLP as independent auditors (Proposal 3). All three proposals passed, with specific vote counts provided for each nominee and proposal. This is a material disclosure as shareholder voting results directly inform investors about governance and executive compensation approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
MetaVia held its Annual Meeting of Stockholders on June 8, 2026, with shareholders voting on five proposals: election of Class I directors, ratification of auditors, approval of a reverse stock split, amendment to the 2022 Equity Incentive Plan increasing available shares by 200,000, and adjournment authority. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of Capricor's Annual Meeting of stockholders held on June 4, 2026. The filing presents detailed voting tallies for all five proposals, including election of eight directors, ratification of auditors, advisory votes on executive compensation and frequency, and a failed amendment to the Certificate of Incorporation. Shareholder vote results are material to investors as they determine board composition and governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Jefferson Capital's Annual Meeting of Stockholders held on June 5, 2026. The filing presents voting tallies for two proposals: election of three Class I directors (David Burton, Thomas Harding, and Thomas Lydon, Jr.) and ratification of Deloitte & Touche LLP as independent auditor. All proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Innodata's Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes for four proposals: election of five directors, ratification of BDO India Services as independent auditors, advisory approval of named executive officer compensation, and approval of the Amended and Restated Equity Compensation Plan. All proposals passed with substantial majorities, making this a material governance event that investors rely upon to assess board composition and executive accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Alarm.com's June 3, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of eight directors, ratification of PricewaterhouseCoopers LLP as auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely on to assess board composition and management accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Ionis Pharmaceuticals held its Annual Meeting of Stockholders on June 4, 2026, with voting results disclosed for five proposals: director elections (Berthelsen and Herman), advisory compensation vote, equity plan amendment (9.5M shares), employee stock purchase plan amendment, and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 disclosure reports the results of AtaiBeckley Inc.'s annual meeting of stockholders held on June 4, 2026, including voting outcomes for the election of three Class I directors (Sabrina Martucci Johnson, Amir Kalali, M.D., and Andrea Heslin Smiley) and ratification of Deloitte & Touche LLP as independent auditor. The filing explicitly states all three nominees were elected and Proposal 2 was approved, making this a standard shareholder vote results disclosure that is material to investors' understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-06-08
Item 8.01
The filing discloses results of a stockholder vote at the 2026 Annual Meeting of Stockholders held on June 8, 2026, where shareholders approved an amendment to the terms of the STRC preferred stock to change dividend payment frequency from monthly to semi-monthly. This is a shareholder vote result on a material corporate action affecting preferred stock terms.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Ambiq Micro's 2026 Annual Meeting held on June 8, 2026, reporting final voting tallies for two proposals: election of Class I directors (Timothy Chen and Ker Zhang, Ph.D.) and ratification of KPMG LLP as independent auditor. The filing directly matches Item 5.07 requirements and is material to investors as it documents stockholder approval of board composition and audit firm selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from the June 5, 2026 Annual Meeting of Stockholders, reporting the outcomes of three proposals: election of three Class II directors (Jane Chung, Connie Matsui, and James Panek), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The tabulated voting results with shares for, against, withheld, and abstaining are the hallmark of Item 5.07 disclosure and constitute material information about corporate governance actions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Red Rock Resorts' Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes for three proposals: election of five directors (Frank J. Fertitta III, Lorenzo J. Fertitta, Robert A. Cashell Jr., Robert E. Lewis, and James E. Nave), a say-on-pay advisory vote, and ratification of Ernst & Young LLP as independent auditor. All proposals passed with majority support, making this a material disclosure of shareholder meeting outcomes required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This 8-K Item 5.07 discloses the final voting results from CG Oncology's June 4, 2026 Annual Meeting of Stockholders, including four proposals: election of two Class II directors (Christina Rossi and Victor Tong, Jr.), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The disclosure presents detailed vote tallies for each matter, which is the core content of Item 5.07 shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-08
Item 5.07
The Company held its 2026 Annual Meeting of Stockholders on June 3, 2026, with voting results reported for four proposals: election of seven directors (all elected with majority support), ratification of Deloitte Touche LLP as independent auditor, advisory vote on executive compensation frequency (1-year preference), and advisory approval of executive compensation policies.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Vince Holding Corp. held its 2026 Annual Meeting on June 4, 2026, with shareholders voting on four proposals: election of Class III director Michael Mardy, ratification of PricewaterhouseCoopers as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the stock plan increasing authorized shares by 1,000,000. The filing reports the tabulated vote counts for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Beam Therapeutics' June 3, 2026 annual meeting, covering three proposals: election of Class III directors (John Evans, John Maraganore, and Christi Shaw), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing directly matches Item 5.07 requirements and presents tabulated vote counts for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the results of Dyne Therapeutics' 2026 Annual Meeting of Stockholders held on June 5, 2026, including votes on director elections (David Lubner, Brian Posner, Jason Rhodes), advisory compensation approval, authorization of additional common shares (200M to 400M), officer exculpation amendment, and auditor ratification. The filing presents tabulated voting results for each matter, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07
Climb Bio held its Annual Meeting of stockholders on June 8, 2026, with voting results on multiple proposals: election of directors Alexander Cumbo and Douglas Williams, ratification of PricewaterhouseCoopers LLP as auditor, rejection of a director removal for cause amendment, and approval of the 2021 Equity Incentive Plan Amendment to include prefunded warrants in the automatic share pool increase mechanism.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from First Advantage's June 5, 2026 Annual Meeting of Stockholders. The filing reports final vote tallies for three proposals: election of Class II directors (James L. Clark, Bridgett R. Price, Mark Gillett), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, and the disclosure is material as it documents the outcome of the annual shareholder meeting and confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 disclosure reports the final results of Bumble Inc.'s 2026 Annual Meeting of Stockholders held on June 4, 2026, including voting outcomes on three proposals: election of three Class II directors (R. Lynn Atchison, Amy M. Griffin, and Sissie L. Hsiao), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides vote tallies certified by the independent inspector of election, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Savara held its annual meeting of stockholders on June 4, 2026, at which shareholders elected six board directors and approved four proposals including a certificate amendment, equity plan increase, auditor ratification, and an advisory vote on executive compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Four Corners Property Trust's June 4, 2026 annual meeting of stockholders. The filing presents final voting tallies for three proposals: election of eight directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports the vote counts and outcomes for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Paymentus Holdings' 2026 Annual Meeting held on June 5, 2026. The filing reports voting outcomes on four matters: election of three Class II directors (Jody Davids, Adam Malinowski, and Gary Trainor), ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and advisory vote on say-on-pay frequency (one year). The detailed vote tallies and high participation rate (97% of voting power present) are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Duluth Holdings' June 3, 2026 annual meeting, covering three proposals: election of eight directors, advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. The filing presents detailed vote tallies by share class for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07
Jaguar Health held its 2026 Annual Meeting of Stockholders on June 8, 2026, with shareholders voting on five proposals including election of a Class II director, ratification of auditors, and approval of dilutive issuances to C/M Capital Master Fund representing more than 19.99% of outstanding shares under two separate agreements (ELOC and Preferred Stock Purchase Agreement).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Palladyne AI Corp. held its Annual Meeting on or before June 8, 2026, with shareholders voting on four proposals: election of Class II director Dennis Weibling, ratification of KPMG LLP as independent auditor, approval of an amendment to the 2021 Equity Incentive Plan increasing available shares by 4,500,000, and approval of restricted stock unit awards totaling 5,360,659 shares to senior executives.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the final voting results from NeuroPace's June 5, 2026 Annual Meeting of Stockholders, including the election of Class II directors (Lisa Andrade and Scott Huennekens) and ratification of PricewaterhouseCoopers LLP as the independent auditor. The disclosure presents vote tallies (For, Against, Withhold, Abstain, Broker Non-Votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from ARKO Corp.'s 2026 Annual Meeting held on June 4, 2026. The filing presents final voting tallies for three proposals: election of six directors, advisory approval of named executive officer compensation, and ratification of Grant Thornton LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material disclosure of shareholder meeting outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Garmin held its annual general meeting on June 5, 2026, with shareholders voting on 14 proposals including approval of financial statements, director elections, executive compensation approvals, and auditor ratification. All matters were approved by shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from AN2 Therapeutics' June 3, 2026 annual meeting, reporting the certified voting outcomes for two proposals: (1) election of three Class I directors (Kabeer Aziz, Gilbert Lynn Marks, M.D., and Rob Readnour, Ph.D.) and (2) ratification of PricewaterhouseCoopers LLP as independent auditor. The filing directly matches Item 5.07 requirements and provides detailed vote tallies including votes for/against, withheld votes, and broker non-votes. Director elections are material governance events affecting board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from Ooma's June 4, 2026 annual meeting, covering three proposals: election of Class II directors (Butenhoff and Mann), ratification of KPMG LLP as independent auditor, and advisory vote on named executive officer compensation. The filing reports final voting tallies for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
DaVita disclosed the final certified results of its June 4, 2026 Annual Meeting of Stockholders, including voting outcomes on the election of nine directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
The filing discloses results of the Company's 2026 Annual Meeting of Shareholders held on June 5, 2026, with detailed voting tabulations for four proposals: election of five directors (Proposal 1), approval of bylaw amendment establishing a staggered board structure (Proposal 2), ratification of HTL International, LLC as independent auditor (Proposal 3), and adjournment authority (Proposal 4). Item 5.07 explicitly presents certified voting results from Broadridge Financial Solutions, Inc., the appointed Inspector of Elections, making this a classic shareholder_vote_results disclosure. The bylaw amendment establishing board classification is material to governance structure and investor assessment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from the June 5, 2026 Annual Meeting of Stockholders under Item 5.07. The filing presents final voting tallies for four proposals: election of nine directors (including one designated by Apax Investor), advisory approval of executive compensation, and ratification of KPMG LLP as independent auditor. These are routine but material governance matters that affect board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes on three proposals: election of seven directors, ratification of Wipfli LLP as independent auditor, and approval of a Stock Plan amendment to increase authorized shares by 200,000. All three proposals passed with clear majorities, and the disclosure includes detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, BROKER NON-VOTE) for each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Fuel Tech's Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes on three proposals: election of four directors (Vincent J. Arnone, Douglas G. Bailey, Sharon L. Jones, and Dennis L. Zeitler), ratification of RSM US LLP as independent auditor, and an advisory vote on executive compensation, with detailed vote tallies for each matter. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 discloses the complete results of Appian's June 3, 2026 annual stockholder meeting, including voting outcomes on five proposals: election of eight directors, ratification of BDO USA as independent auditor, advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and approval of the amended 2017 Equity Incentive Plan. The detailed vote tallies for each proposal and director nominee are material to investors assessing corporate governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
SI-BONE held its Annual Meeting of Stockholders on June 8, 2026, with shareholders voting on three proposals: election of directors (Jeffrey W. Dunn and John G. Freund, M.D.), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. All three matters passed.
View raw filing on EDGAR →